Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mesa Laboratories (MLAB) EBT (2016 - 2025)

Mesa Laboratories' EBT history spans 16 years, with the latest figure at $4.9 million for Q4 2025.

  • For Q4 2025, EBT rose 322.78% year-over-year to $4.9 million; the TTM value through Dec 2025 reached $14.3 million, up 105.29%, while the annual FY2025 figure was $6.0 million, 102.16% up from the prior year.
  • EBT for Q4 2025 was $4.9 million at Mesa Laboratories, up from $1.9 million in the prior quarter.
  • Across five years, EBT topped out at $7.0 million in Q2 2025 and bottomed at -$275.3 million in Q1 2024.
  • The 5-year median for EBT is $1.6 million (2021), against an average of -$12.4 million.
  • The largest annual shift saw EBT skyrocketed 11831.71% in 2021 before it tumbled 99297.83% in 2024.
  • A 5-year view of EBT shows it stood at -$2.3 million in 2021, then surged by 181.85% to $1.9 million in 2022, then increased by 1.57% to $1.9 million in 2023, then plummeted by 213.93% to -$2.2 million in 2024, then surged by 322.78% to $4.9 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's EBT are $4.9 million (Q4 2025), $1.9 million (Q3 2025), and $7.0 million (Q2 2025).